RMD

ResMed
D

RMD

231.520
USD
-1.32
(-0.57%)
مغلق
حجم التداول
11,098
الربح لكل سهم
9
العائد الربحي
0.89
P/E
27
حجم السوق
34,002,627,466
أصول ذات صلة
    ABT
    ABT
    1.785
    (1.34%)
    134.950 USD
    B
    BAX
    0.425
    (1.27%)
    33.840 USD
    BDX
    BDX
    -0.590
    (-0.26%)
    227.450 USD
    BSX
    BSX
    -0.840
    (-0.80%)
    104.480 USD
    EW
    EW
    -1.380
    (-1.85%)
    73.300 USD
    JNJ
    JNJ
    2.680
    (1.68%)
    162.370 USD
    MDT
    MDT
    2.000
    (2.27%)
    89.940 USD
    P
    PRGO
    0.090
    (0.36%)
    25.340 USD
    SYK
    SYK
    -3.72
    (-0.96%)
    382.74 USD
    ZBH
    ZBH
    1.250
    (1.21%)
    104.890 USD
    المزيد
الأخبار المقالات

العنوان: ResMed

القطاع: Healthcare
الصناعة: Medical Instruments & Supplies
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.